Difference between revisions of "Phenytoin toxicity"

From WikEM
Jump to: navigation, search
(Text replacement - "-->" to "→")
(Clinical Features)
Line 23: Line 23:
 
**edema, pain, ischemia, tissue necrosis, compartment syndrome
 
**edema, pain, ischemia, tissue necrosis, compartment syndrome
 
*Anticonvulsant hypersensitivity syndrome
 
*Anticonvulsant hypersensitivity syndrome
**Eosinophilia, [[rash]], pseudolymphoma, [[SLE]], pancytopenia, [[hepatitis]], pneumonitis
+
**Fever, eosinophilia, [[rash]], pseudolymphoma, [[SLE]], pancytopenia, [[hepatitis]], pneumonitis, pharyngitis, [[rhabdomyolysis]]
 +
**Mortality rate of 10%
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==

Revision as of 23:55, 9 May 2017

Background

  • Mortality is extremely rare after intentional overdose if good supportive care is provided
  • Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form → myocardia depression & cardiac arrest)
  • 90% protein bound; dialysis ineffective

Clinical Features

  • CV (only with IV form)
  • Neuro
    • Nystagmus
      • First only with forced lateral gaze; later becomes spontaneous
      • May disappear at higher levels
    • Ataxia
    • Decreased LOC
  • GI
  • Skin
    • tissue infiltration (IV) → "purple glove syndrome"
    • edema, pain, ischemia, tissue necrosis, compartment syndrome
  • Anticonvulsant hypersensitivity syndrome

Differential Diagnosis

Evaluation

Toxicity symptoms by phenytoin level^

Level Sypmtoms
>10 Usually no symptoms
10-20 Occasional mild nystagmus
20-30 Nystagmus
30-40 Ataxia, slurred speech, Nausea/vomiting
40-50 Lethargy, confusion
>50 Coma, seizure (rare)

^Provides a rough guide only; neither sensitive nor specific

Management

Disposition

  • Cannot base on phenytoin level (erratic absorption after PO overdose)
    • Consider discharge if patient has only mild symptoms and serial phenytoin levels decline

See Also

References